Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling itchy on Mounjaro is a recognised side effect that some people notice, particularly in the weeks after starting treatment or following a dose increase. Itching can range from mild skin irritation at the injection site to a more generalised sensation across the body. It is almost always manageable and, in most cases, settles without needing to stop treatment. That said, itching can occasionally signal something that warrants a closer look — so understanding what is likely, what is less likely, and when to act is genuinely useful. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before treatment begins, and your aftercare team is there if new symptoms arise once you are started.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most straightforward reason for localised itching is the mechanical act of injection itself, combined with your skin's response to the formulation being delivered into the subcutaneous tissue. Tirzepatide is delivered in an inactive carrier solution, and some people's skin reacts with brief redness, warmth and an itch that typically arrives within an hour and clears by the next day. This is an expected local reaction rather than an allergy, and it tends to diminish over the first few weeks as your body adjusts.
A few practical steps help here. Letting the pen sit out until it reaches room temperature before you inject (most people tuck it on the fridge door shelf so it is easy to reach at the same time each week) can noticeably reduce stinging and the itch that follows. Rotating your injection site each week also prevents repeated trauma to the same patch of skin. The tirzepatide overview on our site covers injection technique in more detail if you are still in the early weeks of treatment.
If the itching at the injection site is accompanied by a raised, warm lump that persists for more than a few days, or if the area spreads, tell your prescriber. Lipohypertrophy (a thickening of subcutaneous fat from repeated injections in exactly the same spot) can cause ongoing localised discomfort, and moving to a fresh area usually resolves it.
A more diffuse, generalised itch (not confined to where you injected) is less common but reported by some people on Mounjaro. The pattern of itching on Mounjaro that patients describe most often is a mild, transient sensation that comes and goes rather than a constant rash. The likeliest explanation is a low-level immune response to tirzepatide as a novel molecule. Your immune system recognises it, mounts a modest reaction, and then learns to leave it alone. For most people this settles within a few weeks and does not require stopping treatment.
Some people also notice itchy skin on Mounjaro because GLP-1 receptor agonists slow gastric emptying and alter bile flow, which can occasionally affect the skin indirectly via changes in liver enzymes or bile acid levels. This is a less well-understood mechanism and is not a reason to stop unless a prescriber investigates and advises otherwise. The NHS tirzepatide medicines page lists skin reactions among the side effects to be aware of, and the MHRA's Yellow Card scheme is available for anyone who wants to formally report a suspected reaction at yellowcard.mhra.gov.uk.
If you are also taking another medicine (for instance a medicine that interacts with tirzepatide's absorption profile) it is worth raising this with your prescriber, as some drug combinations can contribute to skin reactions.
This is the question worth being clear on. The vast majority of itching on Mounjaro is mild and resolves on its own. However, itching can be an early sign of a serious allergic reaction (anaphylaxis or severe hypersensitivity), and the difference matters.
Seek immediate medical help (call 999 or go to A&E) if itching occurs alongside any of the following: swelling of the face, lips, throat or tongue; difficulty breathing or swallowing; a rapidly spreading raised rash or hives; feeling faint or lightheaded. These symptoms together suggest anaphylaxis, which is rare with tirzepatide but requires emergency treatment. Do not wait to see if it settles.
A less urgent but still important situation is itching that appears specifically in the upper right abdomen, under the ribs, especially if accompanied by nausea or jaundice. This can point to gallbladder involvement, which is a known area of monitoring on GLP-1 medicines. Tell your prescriber if this pattern develops. More on skin reactions during Mounjaro treatment can help you distinguish between the routine and the reportable.
For mild, localised injection-site itching, an over-the-counter antihistamine tablet taken on injection day can take the edge off, but check with your prescriber or pharmacist before adding any new medicine, including antihistamines, to your routine. A gentle, fragrance-free moisturiser applied to the surrounding area (not the actual site before injection) can soothe dry or irritated skin without interfering with your pen.
Avoid scratching vigorously; it increases histamine release and tends to make the itch feel worse rather than better. Cool compresses applied briefly after injection are often more effective. For itching that affects specific areas in unexpected ways (the scalp, for example, which some people report, or more sensitive areas) there are targeted explanations available.
People sometimes ask whether a dose adjustment would help. That is a clinical decision. If itching is significantly disrupting daily life and has persisted beyond a few weeks, it is worth raising formally with your prescriber so they can assess whether it is related to the current dose or something else entirely. You can explore treatment options and speak to a prescriber through our consultation page, where our team handles exactly these kinds of aftercare questions.
Cost is sometimes a concern for people managing ongoing treatment; our Mounjaro price comparison guide sets out what a legitimate, clinically supported private prescription typically costs in the UK, and what the price difference between providers often reflects.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.